Are You Looking for a Top Momentum Pick? Why Vaxcyte, Inc. (PCVX) is a Great Choice

Core Viewpoint - Vaxcyte, Inc. (PCVX) demonstrates strong momentum with significant price increases over the past quarter and year, outperforming the S&P 500 index [1][12]. Company Performance - Shares of Vaxcyte, Inc. have risen 27.43% over the past quarter and 79.98% over the last year, while the S&P 500 has increased by 7.48% and 21.12%, respectively [1]. - The stock currently holds a Momentum Style Score of B, indicating solid momentum potential [6][12]. - Over the past week, PCVX shares increased by 2.96%, outperforming the Zacks Medical - Biomedical and Genetics industry, which rose by 2.38% [14]. Earnings Outlook - In the last 60 days, one earnings estimate for PCVX has moved higher, while none have moved lower, resulting in a consensus estimate increase from -$3.96 to -$3.93 [15]. - For the next fiscal year, one estimate has also moved upwards with no downward revisions during the same period [15]. Trading Volume - The average 20-day trading volume for PCVX is 718,807 shares, which is a useful indicator of market interest and price movement [11].